Slimming food supplements adulterated with sibutramine and phenolphthalein  Too Fat Part Two!... … , double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects (S)-3-[(Benzyloxy) methyl] morpholine hydrochloride: a nonstimulant appetite suppressant without conventional neurotransmitter releasing properties 1-(m-Chlorophenyl) piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain 10. Drugs Affecting Cholinergic Neurotransmission 101 Things to Do Before You Diet: Because Looking Great Isn't Just about Losing Weight 19 Diabetes and Herbal 3 CNTF and Related Neurokines 360-Degree Perspectives on Obesity 365 Skinny Smoothies: Healthy, Never-Boring Recipes with 52 Weekly Shopping Lists for Stress-Free Weight Loss 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure 5-HTP: The natural way to overcome depression, obesity, and insomnia 5-Hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity 50 Ways to Boost Your Metabolism: How Mustard, Red Wine, and Days at the Beach Can Help You Lose Weight & Stay Healthy 7 Acetylcholinesterase inhibitory activity of spices and culinary herbs 7 Weight Management 9 Best Thermogenic Fat Burners in 2022 for Weight Loss A behavioral approach to weight management A Behavioural Genetic Model of the Mechanisms Underlying the Link Between Obesity and Dimensional Measures of Attention-Deficit/Hyperactivity Disorder (ADHD) A bidirectional network for appetite control in larval zebrafish A bidirectional network for appetite control in larval zebrafish A bidirectional network for appetite control in zebrafish A botanical approach to managing obesity A cholinergic basal forebrain feeding circuit modulates appetite suppression A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism A Comparison Study between Orlistat and Moringa Oleifera as an Appetite Suppressant in Case of Obese Patients A content analysis of marketing on the packages of dietary supplements for weight loss and muscle building A contextual analysis of obesity and smoking among women in Oklahoma City A Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization A critical review on obesity: Herbal approach, bioactive compounds, and their mechanism A dual role for astroglia in substituted amphetamine-induced serotonin nerve degeneration: Neuroprotective and neurotoxic A flavonoid-rich fraction of Monolluma quadrangula inhibits xanthine oxidase and ameliorates potassium oxonate-induced hyperuricemia in rats A Functional Magnetic Resonance Imaging Study Evaluating the Effects of Intranasal Insulin on Food Related Reward and Appetite A GC–EI-MS-MS method for simultaneous determination of seven adulterants in slimming functional foods A herbal approach to obesity Management: a review A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening A history of neuromuscular block and its antagonism A low carbohydrate diet: Treating obesity related disorders in adults A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial A Mechanistic Review of Anti-Obesity Drugs A medicinal plants survey for treatment of obesity A Multi-Ingredient Supplement Protects against Obesity and Infertility in Western Diet-Fed Mice A multimodal approach to the treatment of obesity A natural solution for obesity: Bioactives for the
Reversal of obesity by targeted ablation of adipose tissue Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents Reversal of diet-induced obesity and diabetes in C57BL/6J mice Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats Leptin Activation of Corticosterone Production in Hepatocytes May Contribute to the Reversal of Obesity and Hyperglycemia in Leptin-Deficient ob/ob Mice Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a β3-adrenoceptor agonist Trends in fatness and the origins of obesity Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture Reversal of Obesity-and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption.... Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy Myocardial fatty acid oxidation rates remain elevated in ob/ob mice despite reversal of obesity and diabetes by caloric restriction Body weight regulation in obese and obese-reduced rats. Inflammation and the IKKβ/IκB/NF-κB axis in obesity-and diet-induced insulin resistance Polycythemia of obesity: further studies of its mechanism and a report of two additional cases Brain responses to obesogenic diets and diet-induced obesity Development of obesity in transgenic mice after genetic ablation of brown adipose tissue Hypothalamic obesity: the autonomic hypothesis and the lateral hypothalamus Role of Endoplasmic Reticulum Stress and c-Jun NH2-Terminal Kinase Pathways in Inflammation and Origin of Obesity and Diabetes Severe orthostatic hypotension following weight reduction surgery The role of beta3-adrenergic receptors in control of brown and white adipose tissues and of energy balance: Reversal of obesity by CL 316,243, a new beta3 … The liver in obesity and type 2 diabetes mellitus Effects of fasting and refeeding on blood pressure are determined by nutritional state, not by body weight change Maternal obesity is associated with younger age at obesity onset in US adolescent offspring followed into adulthood Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity Using mouse models to dissect the genetics of obesity Energy balance in reversible obesity Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia Pathophysiologic changes of obesity Role of the autonomic nervous system in the development of ventromedial hypothalamic obesity Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation Pathogenesis of type 2 diabetes mellitus Internal regulation and the evolution of normal growth as the basis for prevention of obesity in
… (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary … … a supplement containing conjugated linoleic acid on dairy performance, milk fatty acid composition, and adipose tissue reactivity to lipolytic challenge in mid … … analogs of lysolecithin and their use in a continuous spectrophotometric assay for lysophospholipases, a method with potential applicability to other lipolytic enzymes … and reduction of fat stores on the antilipolytic alpha 2-adrenoceptor in hamster adipocytes: comparison with adenosine and beta-adrenergic lipolytic … … and Yarrowia lipolytica strains in dried fermented sausage manufacture. Part 1: Evaluation of their effects on microbial evolution, lipolytic and proteolytic patterns … breast adenocarcinoma (MCF-7) cells proliferation in co-culture with human adipocytes in three dimensional collagen gel matrix: norepinephrine as a lipolytic … … diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to … … during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic … … high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin: cholesterol … … human breast adenocarcinoma [MCF-7] cells proliferation in co-culture with human adipocytes in three dimensional collagen gel matrix: norepinephrine as a lipolytic … … HYPERSENSITIVE RESPONSE OF BEAN INOCULATED WITH PSEUDOMONAS SYRINGAE PV. PHASEOLICOLA RACE 1 (PHASEOLUS VULGARIS, LIPOLYTIC … … in biological materials. II. The measurement of adenosine 3', 5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to … … IN THE EARLY PERIODS AFTER IONIZING RADIATION AND THE EFFECT OF WHOLE-BODY ALPHAIRRADIATION ON LIPOLYTIC ENZYME INDUCTION BY … … of 1-substituted 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinolines: inhibition of 3H-dopamine accumulation by rat brain slices and lipolytic activity with isolated mouse … … of a versatile cassette for directional genome walking using cassette ligation-mediated PCR and its application in the cloning of complete lipolytic genes from Bacillus … … of an axenic fungal isolate of aspergillus sp.(mbl-1511) and its subsequent improvement for enhanced extracellular lipolytic potential through monoculture … … of Corticotropin. III. The Synthesis of L-Histidyl-L-phenylalanyl-L-arginyl-L-tryptophan, the Smallest Peptide Exhibiting the Melanocyte-stimulating and the Lipolytic … … of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins … … of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic … … of preadipocytes with fish oil, mixed oil, or soybean oil-based lipid emulsions have differential effects on the regulation of lipogenic and lipolytic genes in mature 3T3 … … of sodium taurodeoxycholate, CaCl2 and albumin on the action of pancreatic lipase on droplets of trioleoylglycerol and the release of lipolytic products into aqueous … … overview of Tityus cisandinus scorpion venom: Transcriptome and mass fingerprinting reveal conserved toxin homologs across the Amazon region and novel lipolytic … … PHOSPHOLIPASE C (CLOSTRIDIUM PERFRINGENS α TOXIN) AND OF INSULIN ON LIPOLYSIS STIMULATED BY LIPOLYTIC HORMONES AND THEOPHYLLINE … regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites
Anti-obesogenic and antidiabetic effects of plants and mushrooms Medicinal plants and phytochemicals with anti-obesogenic potentials: A review The anti-obesogenic effects of dietary berry fruits: A review Potential of enhancing anti-obesogenic agriceuticals by applying sustainable fertilizers during plant cultivation Mechanisms of action for the anti-obesogenic activities of phytochemicals The anti-obesogenic effects and underpinning mechanisms of fermented plant-based foods: A review Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice Antioxidative, anti-inflammatory, anti-obesogenic, and antidiabetic properties of tea polyphenols—The positive impact of regular tea consumption as an … The conversion of β-carotene to vitamin A in adipocytes drives the anti-obesogenic effects of β-carotene in mice Saponins are responsible for the anti-obesogenic activity of Acacia concinna Dietary n-3 long-chain polyunsaturated fatty acids upregulate energy dissipating metabolic pathways conveying anti-obesogenic effects in mice Phenolic Profile, Antioxidant Activity, and Anti-obesogenic Bioactivity of Mao Luang Fruits (Antidesma bunius L.) Prawn shell chitosan has anti-obesogenic properties, influencing both nutrient digestibility and microbial populations in a pig model Anti-obesogenic effect of apple cider vinegar in rats subjected to a high fat diet Potential Anti-obesogenic Effects of Ginkgo biloba Observed in Epididymal White Adipose Tissue of Obese Rats Potential anti-obesogenic properties of non-digestible carbohydrates: specific focus on resistant dextrin The Allium Derivate Propyl Propane Thiosulfinate Exerts Anti-Obesogenic Effects in a Murine Model of Diet-Induced Obesity Prawn Shell Chitosan Exhibits Anti-Obesogenic Potential through Alterations to Appetite, Affecting Feeding Behaviour and Satiety Signals In Vivo Anti-Obesogenic Effects of Sulforaphane-Rich Broccoli (Brassica oleracea var. italica) Sprouts and Myrosinase-Rich Mustard (Sinapis alba L.) Seeds In Vitro and In … Selection of Thai medicinal plants with anti-obesogenic potential via in vitro methods Caffeic acid and hydroxytyrosol have anti-obesogenic properties in zebrafish and rainbow trout models Arabinoxylans and gelled arabinoxylans used as anti-obesogenic agents could protect the stability of intestinal microbiota of rats consuming high-fat diets Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: a population-based study Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster Anti‐obesogenic effects of calcium prevent changes in the GLP‐1 profile in adult rats primed by early weaning Copaiba oleoresin presents anti-obesogenic effect and mitigates inflammation and redox imbalance in adipose tissue Anti-obesity natural products tested in juvenile zebrafish obesogenic tests and mouse 3T3-L1 adipogenesis assays Putative hormone with anti-obesogenic and insulin-sensitizing effect Zebrafish obesogenic test identifies anti‐adipogenic fraction in Moringa oreifera leaf extracts A long-term obesogenic high-fat diet in mice partially dampens the anti-frailty benefits of late-life intermittent fasting The Anti-Obesogenic Effect of Lean Fish Species Is Influenced by the Fatty Acid Composition in Fish Fillets Obesity causes irreversible mitochondria failure in visceral adipose tissue despite successful anti-obesogenic lifestyle-based interventions Molecular Mechanisms of Adipogenesis: The Anti-Obesogenic Role of AMP-Activated Protein Kinase and Recently Reported Plant Products Mechanistic analysis of Thai medicinal plants on anti-obesogenic activity [an abstract of dissertation and a summary of dissertation review] Investigating the antioxidant, immunomodulatory and anti-obesogenic propertiesof novel BSG-derived extracts and their potential as
Of mice and men: The physiological role of adipose triglyceride lipase (ATGL) Hints on ATGL implications in cancer: beyond bioenergetic clues Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl) Recent advances on the role of ATGL in cancer Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-α in 3T3-L1 adipocytes and is a target for transactivation by PPARγ ATGL promotes autophagy/lipophagy via SIRT1 to control hepatic lipid droplet catabolism FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype Cold-induced thermogenesis depends on ATGL-mediated lipolysis in cardiac muscle, but not brown adipose tissue ATGL is a biosynthetic enzyme for fatty acid esters of hydroxy fatty acids Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL) Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2 ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK AMPK phosphorylates desnutrin/ATGL and hormone-sensitive lipase to regulate lipolysis and fatty acid oxidation within adipose tissue Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and following stimulated contraction Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL) Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific Fasting, but not exercise, increases adipose triglyceride lipase (ATGL) protein and reduces G (0)/G (1) switch gene 2 (G0S2) protein and mRNA content in human … Effect of endurance training intensity (low, moderate and high) on the expression of skeletal muscle ATGL protein and serum
The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta A new pancreatic lipase inhibitor from Broussonetia kanzinoki Quercetin is a promising pancreatic lipase inhibitor in reducing fat absorption in vivo Weight Gain Reduction in Mice Fed Panax ginseng Saponin, a Pancreatic Lipase Inhibitor Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor Antiobesity action of ɛ-polylysine, a potent inhibitor of pancreatic lipase Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor High-Resolution Bioassay Profiling with Complemented Sensitivity and Resolution for Pancreatic Lipase Inhibitor Screening Proteinaceous pancreatic lipase inhibitor from the seed of Litchi chinensis Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini I. Producing organism, fermentation, isolation and biological activity Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini II. Chemistry and structure elucidation Elucidating the Biosynthetic Pathway for Vibralactone: A Pancreatic Lipase Inhibitor with a Fused Bicyclic β‐Lactone Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate Development of QSAR model using machine learning and molecular docking study of polyphenol derivatives against obesity as pancreatic lipase inhibitor Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Cassia grandis Lf nanodispersion is a hypoglycemic product with a potent α-glucosidase and pancreatic lipase inhibitor effect … aldol-lactonization (TMAL) reaction: A concise and highly diastereoselective route to β-lactones applied to the total synthesis of the potent pancreatic lipase inhibitor … In-vitro functional efficacy of extracts from Phyllanthus emblica, Eucalyptus globulus, Tinospora cordifolia as pancreatic lipase inhibitor and source of anti-oxidant in … Phytochemical and Biological Profile of Moricandia arvensis (L.) DC.: An Inhibitor of Pancreatic Lipase Theophylline extracted from fu brick tea affects the metabolism of preadipocytes and body fat in mice as a pancreatic lipase inhibitor The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat) Proteinous pancreatic lipase inhibitor is responsible for the antiobesity effect of young barley (Hordeum vulgare L.) leaf extract Peptide inhibitor of pancreatic lipase selected by phage display using different elution strategies Synthesis and Study of a Lipophilic α-Keto Amide Inhibitor of Pancreatic Lipase Utilization of Agro-Waste of Piper longum for a Potential Pancreatic Lipase Inhibitor 5-Hydroxy-7-(4′-hydroxy-3′-methoxyphenyl)-1-phenyl-3-heptanone: a pancreatic lipase inhibitor isolated from Alpinia officinarum Operon for biosynthesis of lipstatin, the beta-lactone inhibitor of human pancreatic lipase Saponin isolates from cucumber (Cucumis sativus L.) fruit mesocarp and their activity as pancreatic lipase inhibitor Functional Imaging and Inhibitor Screening of Human Pancreatic Lipase by a Resorufin-Based Fluorescent Probe Large spectral changes accompany the conformational transition of human pancreatic lipase induced by acylation with the inhibitor
Possible anti-obesity therapeutics from nature–A review Anti-obesity drugs: past, present and future Anti-obesity drugs: a review about their effects and safety Anti-obesity action of oolong tea Anti-obesity therapies The obesity pipeline: current strategies in the development of anti-obesity drugs The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile Anti-obesity drugs: a review about their effects and their safety Treatment of obesity: an update on anti‐obesity medications A systematic review of anti-obesity medicinal plants-an update Anti‐obesity effects of green tea: from bedside to bench Food ingredients as anti-obesity agents: a review The anti-obesity potential of sigmoidin A Natural products in anti-obesity therapy Mechanisms underlying current and future anti-obesity drugs Rise and fall of anti-obesity drugs The utility of animal models to evaluate novel anti‐obesity agents Screening of crude plant extracts with anti-obesity activity Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model Are medical students aware of their anti-obesity bias? Orlistat: its current status as an anti-obesity drug Food components with anti-obesity effect Anti-obesity effects of tea catechins in humans Vegetables containing phytochemicals with potential anti-obesity properties: A review Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats Antidiabetes and Anti-Obesity Activity of Lagerstroemia speciosa Do we need anti‐obesity drugs? Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732 Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons Propionate. Anti-obesity and satiety enhancing factor? Anti-obesity and antihyperlipidaemic effect of Hunteria umbellata seed extract in experimental hyperlipidaemia PYY3‐36 as an anti‐obesity drug target Efficacy and safety of anti‐obesity drugs in children and adolescents: systematic review and meta‐analysis Anti-obesity drugs: a critical review of current therapies and future opportunities Anti-obesity drugs and neural circuits of feeding Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Anti-obesity effects of natural products Gluttony or sloth': Critical geographies of bodies and morality in (anti) obesity policy Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways Disability and the anti‐obesity offensive Anti-obesity compounds in green leaves of Eucommia ulmoides Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs Phenolic compounds and plant extracts as potential natural anti-obesity substances Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice Anti‐obesity effects of long‐chain omega‐3 polyunsaturated fatty acids Mechanisms of hypolipidemic and anti‐obesity effects of tea and tea polyphenols Anti-diabetes and anti-obesity medications: effects on weight in people with diabetes The discovery and status of sibutramine as an anti-obesity drug Current strategies in the development of anti-obesity drugs and their safety concerns Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice Measuring fatness, governing bodies: The spatialities of the Body Mass Index (BMI) in anti‐obesity politics Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects Sibutramine:
GSK3 inhibitors: development and therapeutic potential The conundrum of GSK3 inhibitors: is it the dawn of a new beginning? Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes GSK3 inhibitors and disease GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals GSK3 inhibitors in the therapeutic development of diabetes, cancer and neurodegeneration: past, present and future Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor The development of potent and selective bisarylmaleimide GSK3 inhibitors Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors Activation of Wnt/β-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytes A modified EpiSC culture condition containing a GSK3 inhibitor can support germline-competent pluripotency in mice The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of … GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels GSK3 inhibitor-induced dentinogenesis using a hydrogel QSAR, docking, and CoMFA studies of GSK3 inhibitors GSK3 inhibitor-BIO regulates proliferation of immortalized pancreatic mesenchymal stem cells (iPMSCs) GSK3 inhibitor-loaded osteotropic Pluronic hydrogel effectively mitigates periodontal tissue damage associated with experimental periodontitis GSK3 inhibitors CHIR99021 and 6-bromoindirubin-3′-oxime inhibit microRNA maturation in mouse embryonic stem cells Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127 From on‐target to off‐target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti‐Trypanosoma brucei drug … Donor cell engineering with GSK3 inhibitor–loaded nanoparticles enhances engraftment after in utero transplantation Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells EGF and a GSK3 inhibitor deplete junctional E-cadherin and stimulate proliferation in the mature mammalian ear Control of Hes7 Expression by Tbx6, the Wnt Pathway and the Chemical Gsk3 Inhibitor LiCl in the Mouse Segmentation Clock Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells Stable generation of serum‐and feeder‐free embryonic stem cell‐derived mice with full germline‐competency by using a GSK3 specific inhibitor The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype Effect of Gsk3 inhibitor CHIR99021 on aneuploidy levels in rat embryonic stem cells GSK3 inhibitors stabilize Wee1 and reduce cerebellar granule cell progenitor proliferation Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline‐competent embryonic
SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells Cardiovascular effects of a novel SIRT 1 activator, SRT 2104, in otherwise healthy cigarette smokers The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase Nobiletin ameliorates hepatic ischemia and reperfusion injury through the activation of SIRT-1/FOXO3a-mediated autophagy and mitochondrial biogenesis SIRT 1‐mediated epigenetic downregulation of plasminogen activator inhibitor‐1 prevents vascular endothelial replicative senescence PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation Treadmill exercise decreases amyloid-β burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer's disease Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity A novel biological role of α‐mangostin in modulating inflammatory response through the activation of SIRT‐1 signaling pathway Two novel SIRT1 activators, SCIC2 and SCIC2. 1, enhance SIRT1-mediated effects in stress response and senescence Peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial … SIRT1/PGC-1 pathway activation triggers autophagy/mitophagy and attenuates oxidative damage in intestinal epithelial cells Probing the mechanism of SIRT1 activation by a 1, 4-dihydropyridine Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation Nutraceutical activators of AMPK/Sirt1 axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-1 infection Pharmacokinetics and tolerability of SRT 2104, a first‐in‐class small molecule activator of SIRT 1, after single and repeated oral administration in man Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis SIRT1 silencing confers neuroprotection through IGF‐1 pathway activation Induction of autophagy and activation of SIRT‐1 deacetylation mechanisms mediate neuroprotection by the pomegranate metabolite urolithin A in BV2 microglia and … SirT1 activator represses the transcription of TNF‑α in THP‑1 cells of a sepsis model via deacetylation of H4K16 Parthenolide Phytosomes Attenuated Gentamicin-Induced Nephrotoxicity in Rats via Activation of Sirt-1, Nrf2, OH-1, and NQO1 Axis SIRT 1 activator loaded inhaled antiangiogenic liposomal formulation development for pulmonary hypertension Oligo-fucoidan improves diabetes-induced renal fibrosis via activation of sirt-1, glp-1r, and nrf2/ho-1: An in vitro and in vivo study Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT). Homocysteine facilitates LOX-1 activation and endothelial death through the PKCβ and SIRT1/HSF1 mechanism: relevance to human hyperhomocysteinaemia … Effect of DiDang Tang Against AlCl3-Induced Oxidative Stress and Apoptosis in PC12 Cells Through
AMPK activation: a therapeutic target for type 2 diabetes? AMPK activators–potential therapeutics for metabolic and other diseases AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure Choreography of AMPK activation Use of cells expressing γ subunit variants to identify diverse mechanisms of AMPK activation Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Effect of AMPK activation on muscle glucose metabolism in conscious rats AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma Antileukemic effects of AMPK activators on BCR-ABL–expressing cells Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation A small molecule AMPK activator protects the heart against ischemia–reperfusion injury SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth Berberine suppresses proinflammatory responses through AMPK activation in macrophages Activation of autophagy in human skeletal muscle is dependent on exercise intensity and AMPK activation Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation Structural basis of AMPK regulation by small molecule activators Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation AICAR, an AMPK activator, has protective effects on alcohol‐induced fatty liver in rats AMPK activation—protean potential for boosting healthspan Potential AMPK activators of cucurbitane triterpenoids from Siraitia grosvenorii Swingle Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect AMPK activation regulates neuronal structure in developing hippocampal neurons AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity Berberine-induced AMPK activation